Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic.
systematic_review · Level I
Where this comes from
- Record sourced from PubMed, PMID 32658285.
- Also identified by DOI 10.1001/jamanetworkopen.2020.15100 and PMC identifier 7358910.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
This systematic review examines current randomized clinical trials of therapeutic agents to treat coronavirus disease 2019 (COVID-19).
Medical subject headings
- Chloroquine
- Coronavirus Infections
- Hydroxychloroquine
- Pneumonia, Viral